4579 — RaQualia Pharma Share News
0.000.00%
Last trade - 00:00Brief: RaQualia Pharma says termination of 5-HT4 partial agonist related license agreement
Brief: RaQualia Pharma signs license agreement with Maruho on selective Na sodium channel blocker
Table: RaQualia Pharma -2017 group forecast
Brief: RaQualia Pharma ends license agreement related to EP4 antagonist
Table: RaQualia Pharma - 9-MTH group results
Brief: RaQualia Pharma announces exercise of options
Brief: RaQualia Pharma says exercise of options
Brief: RaQualia Pharma says exercise of options
Table: RaQualia Pharma - 6-MTH group results
Brief: RaQualia Pharma confirms to receive upfront payment
Table: RaQualia Pharma -Q1 group results
Table: RaQualia Pharma -2017 group forecast
Table: RaQualia Pharma -2017 group forecast
Table: RaQualia Pharma -2017 parent forecast
Table: RaQualia Pharma -2017 parent forecast
Table: RaQualia Pharma -2016 parent results
Table: RaQualia Pharma -2016 parent forecast
Brief: RaQualia Pharma to fully acquire TMRC via stock swap
Table: RaQualia Pharma -9-MTH parent results